However, in a neuroendocrine PC model, anti-Sema4D therapy, while inhibiting tumor growth and prolonging survival, unexpectedly promoted tumor invasiveness through retrograde signaling mediated by macrophages [132]. Here, SEMA4D is linked to neoplasm.